Going Green

Researchers routinely prepare proteins in test tubes using the in vitro translation (IVT) reaction.1 These reactions are fast, efficient, and reasonably cost-effective. They are also highly flexible. Proteins can be synthesized either from RNA transcribed in vitro (uncoupled), or from plasmid DNA via a coupled transcription/translation system. In addition, the proteins are easily labeled with [35S]-methionine or biotinylated lysine simply by addition of the labeling reagent to the reaction. Unfo

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Now a third labeling option is available, which promises to alleviate the shortcomings of other methods. Madison, Wis.-based Promega Corp.'s FluoroTect™ GreenLys in vitro translation labeling system is a BODIPY®-FL-labeled lysine residue coupled to tRNALys. BODIPY is a fluorophore, so proteins prepared in vitro may be immediately visualized following electrophoresis, using a laser-based fluorescent imaging system (such as the FluorImager® SI, FluorImager 595, or Typhoon™ 8600, from Molecular Dynamics, or with the FMBIO® II from Hitachi Instruments). The BODIPY label has an absorption maximum of 502 nm, and an emission maximum of 510 nm.

To use this system, scientists need only add 1-2 µl of the FluoroTect reagent to a standard IVT reaction. Since it is supplied as a charged tRNA, the labeled tRNALys is immediately available to the ribosomes, without the need for in vitro charging. Because of the ability to detect labeled proteins "in-gel," researchers can avoid traditional ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies